Salvia BioElectronics
Latest round
- Series B
Last raised
- May 2025
Total raised
- $95M
Investors
- 11
About Salvia BioElectronics
, founded in 2017 in Eindhoven, Netherlands, focuses on neuromodulation therapies.Salvia BioElectronics specializes in pioneering neuromodulation therapy, primarily targeting chronic migraine and cluster headache treatment through its flagship product, MySalvia Therapy. This innovative therapy features an ultra-thin implant designed to comprehensively stimulate key nerves associated with migraine pathophysiology, thereby aiming to provide significant relief for patients suffering from these debilitating conditions. Currently, the therapy is in the clinical evaluation phase and has not yet received commercial approval. Salvia's customer base consists of healthcare professionals and institutions in the United States, Europe, and Australia, as well as individuals suffering from chronic migraines and cluster headaches, who are ultimately the end users of the therapy. The company’s revenue model is based on a direct-to-consumer approach, allowing individuals to access MySalvia Therapy through healthcare providers or specialist clinics once the product is commercially available. Transactions will occur as part of partnerships with healthcare institutions and through direct sales to patients, facilitating a streamlined process for obtaining treatment. The pricing structure for MySalvia Therapy will include options for individual treatment plans, allowing for personalized care tailored to the needs of chronic migraine sufferers.V. Salvia plans to enhance its product offerings and is focused on expanding into the United States, Europe, and Australia by 2026.
Who invested in Salvia BioElectronics
11 investors across 4 rounds
See all investors in Salvia BioElectronics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Salvia BioElectronics
Who invested in Salvia BioElectronics?
Salvia BioElectronics has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Salvia BioElectronics raised?
Salvia BioElectronics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Salvia BioElectronics last raise money?
Salvia BioElectronics's most recent round on record is a Series B, in May 2025.
What does Salvia BioElectronics do?
, founded in 2017 in Eindhoven, Netherlands, focuses on neuromodulation therapies.
Where is Salvia BioElectronics headquartered?
Salvia BioElectronics is headquartered in Eindhoven, Netherlands.
Which VCs invest in companies like Salvia BioElectronics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Salvia BioElectronics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Salvia BioElectronics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.